Contact PI/Project LeaderWELLS, KEVIN DALE Other PIs
Awardee OrganizationUNIVERSITY OF MISSOURI-COLUMBIA
Description
Abstract Text
Project Summary – Overall
The role of the Genome Editing Testing Section will be to validate unique reporter models created by the
Animal Model Production Section and to test novel delivery methods and reagents provided by other
members of the Somatic Cell Genome Editing (SCGE) Consortium. Additionally, the Genome Editing
Testing Section will be responsible for creating detailed standard operating procedures (SOPs) and
comprehensive reports for testing new genome editing technologies. It is essential to have a well-
established pipeline for the validation and testing of new genome editing technology to facilitate proper
refinement of the tools while ensuring the safety of the technology. The Genome Editing Testing Section will
streamline the testing process while maintaining a comprehensive and rigorous comparative analysis of
new genome editing tools and delivery systems. Our group is ideally suited to provide this testing due to our
unique composition of individuals that are experienced with pig production, swine biomedical models,
operate successful labs that routinely test cutting-edge genome editing technology, and are associated with
world-renowned National Swine Resource and Research Center (NSRRC). The Genome Editing Testing
Section will have a significant impact on the overall MU Swine Testing Center for Genome Editing
Technologies’ ability to accurately assess new technologies and further facilitate the ability to use genome
editing in therapeutic circumstances.
Public Health Relevance Statement
Relevance to Public Health
This project will devise methods to test the safety and efficacy of genome editing reagents.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Animal ModelAnimalsCollaborationsCommunitiesEffectivenessEnsureEvaluationFamily suidaeGenesGoalsIndividualInflammationInfrastructureMethodsModelingProceduresProcessProductionPublic HealthReagentReporterReportingResearchResourcesRoleSafetyStandardizationSystemTechnologyTestingTherapeuticTranslationsUnited States National Institutes of HealthValidationbench to bedsideclinical applicationcohortcomparativeexperiencegenome editinghuman diseaseimmunogenicityin vivomembernew technologynovelnovel therapeutic interventionpreservationprogramssafety testingsomatic cell gene editingtool
No Sub Projects information available for 1U42OD027090-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U42OD027090-01
Patents
No Patents information available for 1U42OD027090-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U42OD027090-01
Clinical Studies
No Clinical Studies information available for 1U42OD027090-01
News and More
Related News Releases
No news release information available for 1U42OD027090-01
History
No Historical information available for 1U42OD027090-01
Similar Projects
No Similar Projects information available for 1U42OD027090-01